BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24433778)

  • 1. Tolerance of anemia: understanding the adaptive physiological mechanisms which promote survival.
    Hare GM
    Transfus Apher Sci; 2014 Feb; 50(1):10-2. PubMed ID: 24433778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessing the risk of hemodilutional anemia: Some new pieces to an old puzzle.
    Tsui AK; Dattani ND; Marsden PA; El-Beheiry MH; Grocott HP; Liu E; Biro GP; Mazer CD; Hare GM
    Can J Anaesth; 2010 Aug; 57(8):779-91. PubMed ID: 20512540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
    Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia.
    Tsui AK; Marsden PA; Mazer CD; Sled JG; Lee KM; Henkelman RM; Cahill LS; Zhou YQ; Chan N; Liu E; Hare GM
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(1):R13-25. PubMed ID: 24760996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role for inducible nitric oxide synthase in the cerebral response to acute hemodilution.
    McLaren AT; Mazer CD; Zhang H; Liu E; Mok L; Hare GM
    Can J Anaesth; 2009 Jul; 56(7):502-9. PubMed ID: 19412649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methemoglobin as a potential biomarker of anemic stress in humans.
    Hare GM; Mu A; Romaschin A; Tsui AK; Shehata N; Beattie WS; Mazer CD
    Can J Anaesth; 2012 Apr; 59(4):348-56. PubMed ID: 22271507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress--The example of anemia?
    Hare GM; Tsui AK; Crawford JH; Patel RP
    Redox Biol; 2013 Jan; 1(1):65-9. PubMed ID: 24024138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment?
    Hare GM; Tsui AK; Ozawa S; Shander A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):85-98. PubMed ID: 23590918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a highly selective β₁ antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats.
    Hu T; Beattie WS; Mazer CD; Leong-Poi H; Fujii H; Wilson DF; Tsui AK; Liu E; Muhammad M; Baker AJ; Hare GM
    Anesth Analg; 2013 Mar; 116(3):649-62. PubMed ID: 23400988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic signaling: some organs are more equal than others. Focus on "Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia".
    Evans RG
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(1):R11-2. PubMed ID: 24760993
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of organ-specific anemia tolerance.
    Lauscher P; Kertscho H; Schmidt O; Zimmermann R; Rosenberger P; Zacharowski K; Meier J
    Crit Care Med; 2013 Apr; 41(4):1037-45. PubMed ID: 23385097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cerebral and renal endothelial nitric oxide synthase gene expression after cardiopulmonary bypass in the rat.
    Mazer CD; Briet F; Blight KR; Stewart DJ; Robb M; Wang Z; Harrington AM; Mak W; Li X; Hare GM
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):13-20. PubMed ID: 17198775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide from neuronal nitric oxide synthase sensitises neurons to hypoxia-induced death via competitive inhibition of cytochrome oxidase.
    Jekabsone A; Neher JJ; Borutaite V; Brown GC
    J Neurochem; 2007 Oct; 103(1):346-56. PubMed ID: 17623038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety?
    Hare GM; Freedman J; David Mazer C
    Can J Anaesth; 2013 Feb; 60(2):168-75. PubMed ID: 23354944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
    Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
    Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodilution and anemia in patients with cardiac disease: what is the safe limit?
    Tircoveanu R; Van der Linden P
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):66-70. PubMed ID: 18195613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treadmill running protects hippocampal neurons from hypobaric hypoxia-induced apoptosis in rats.
    Lin C; Wu CJ; Wei IH; Tsai MH; Chang NW; Yang TT; Kuo YM
    Neuroscience; 2013 Feb; 231():216-24. PubMed ID: 23219906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylhydrazine-induced anemia causes nitric-oxide-mediated upregulation of the angiogenic pathway in Notothenia coriiceps.
    Borley KA; Beers JM; Sidell BD
    J Exp Biol; 2010 Aug; 213(Pt 16):2865-72. PubMed ID: 20675556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1alpha under the control of nitric oxide.
    Brüne B; Zhou J
    Methods Enzymol; 2007; 435():463-78. PubMed ID: 17998069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.